Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology 14. March 2026
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 95924  Previews Next
   
   Articles 1 - 20 / 1918471  
   
Correspondence on "Survival in advanced staged ovarian cancer treated without cytoreductive surgery-a systematic review and exploratory meta-analysis" by Garkhail et al.
Int J Gynecol Cancer
Guo P, Lin J, Liu C.
PMID: 41826139 [PubMed - as supplied by publisher]


Navigating Diagnostic and Therapeutic Challenges in Rare SMARCA4-deficient Lung Cancer: Achieving Partial Response Through Regimen Change.
Arch Bronconeumol
Zeng B, Huang X, Lai B.
PMID: 41826138 [PubMed - as supplied by publisher]


[Adherence to lung cancer screening by low-dose chest CT: Results of the first round of screening in the Multicenter Interventional DeCanPHaR Study].
Rev Mal Respir
Strentz P, Rinaldo F, Jacquet-Pierroulet C, Baumann E, Fonne S, Bizot C, Hammas K, Palpacuer C, Debieuvre D, Decanphar Study Group.
PMID: 41826137 [PubMed - as supplied by publisher]


Economic Burden of Oral Cancer and Resource-Stratified Approach to the Management of Gingivobuccal Cancers.
Oral Maxillofac Surg Clin North Am
Chatni S, B V M, Pandya K.
PMID: 41826129 [PubMed - as supplied by publisher]


Clinical Trial Protocol for the Apa/Enza-short Study: A Randomized Nationwide Study of Shortened 12-Month Duration of Androgen Receptor Signaling Agent in Combination With Androgen Deprivation Therapy in Patients With Metastatic Low-volume Castration-sensitive Prostate Cancer.
Eur Urol Focus
Hamidikia M, van Dijk TC, Martens JWM, Isebia KT, de Wit R, Beije N.
PMID: 41826123 [PubMed - as supplied by publisher]


Multi-Parametric Super-Resolution Ultrasound for Evaluating Breast Cancer Characteristics: Improved Diagnostic Performance Over Contrast-Enhanced Ultrasound.
Ultrasound Med Biol
Liu Z, Wang L, Zhou Y, Li Q, Yuan L.
PMID: 41826088 [PubMed - as supplied by publisher]


Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer.
Clin Colorectal Cancer
Bocobo A, Whitman J, Keenan BP, Koser KL, Kidder WA, Piawah S, Van Loon K, Behr SC, Kolli KP, Chen X, Onodera C, Pande M, Pollak M, Wang R, Babdor J, Spitzer MH, Zhang L, Fong L, Atreya CE.
PMID: 41826077 [PubMed - as supplied by publisher]


Quality Assessment of Online Arabic Information on Head and Neck Cancer: An Infodemiological Study.
Cancer Control
Aljabab SA, Bin Idris R, Alaluan HF, Alayed Y, Alsogheir AM.
PMID: 41826065 [PubMed - indexed for MEDLINE]


Lung cancer as a global health challenge: Multidimensional biomarker research and therapeutic advances.
Int J Cancer
Jin D, Zhong L, Chen L.
PMID: 41826059 [PubMed - as supplied by publisher]


Development of an evaluation index system for assessing the information support effect on patients with breast cancer undergoing radiotherapy.
Appl Nurs Res
Chen X, Wang Z, Liu H, Zhang F, Liu Y, Yang X.
PMID: 41826027 [PubMed - in process]


Role of solute carrier family 7 member 7 in cancer: opportunities for tumor microenvironment research.
J Immunother Cancer
Zhang Z, Lv J, Li J.
PMID: 41825936 [PubMed - indexed for MEDLINE]


Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer.
J Immunother Cancer
Ghiringhelli F, Kim R, Macarulla T, Moreno I, Abdul Razak A, Rodon Ahnert J, Liao CY, Davis SL, Mahipal A, Marron T, Raimbourg J, Kaplon H, Geronimi J, Harouki N, Rodrigues C, Darcel P, Jakobsen JS, Skartved N, Hald R, Lopez-Ravnborg D, He P, Ianopoulos X, Askoxylakis V, Lakhani N.
PMID: 41825935 [PubMed - indexed for MEDLINE]


Blood Based Biomarkers for Predicting Treatment Response to Immune Checkpoint Inhibitors After EGFR-TKI Resistance in Non-Small Cell Lung Cancer.
Thorac Cancer
Park MS, Lim JH, Park N, Park E, Lim A, Lee S, Cho Y, Kwak S, Lee M, Seo D, Kim L, Ryu WK, Ryu JS, Kim EY, Hong SS, Jung KH.
PMID: 41825931 [PubMed - indexed for MEDLINE]


Bridging FDA Adverse Event Reporting System (FAERS) and Clinical Practice: Comprehensive Characterization of Immune Checkpoint Inhibitors Toxicities in Geriatric Lung Cancer Patients.
Thorac Cancer
Tian Y, Nie X, Yuan Y, Wei Q, Zhang S, Li L.
PMID: 41825930 [PubMed - indexed for MEDLINE]


Temporal trends in cervical cancer incidence and mortality in economically emerging countries, 1992-2021: an age-period-cohort analysis.
BMJ Glob Health
Dun C, Su Y, Basu P, Zhao X, Hu S, Muwonge R, Qiao Y, Zhao F.
PMID: 41825913 [PubMed - indexed for MEDLINE]


Advanced imaging (narrow band and acetic acid chromoendoscopy) and guided biopsies in surveillance of Barrett's oesophagus: a systematic review.
BMJ Open Gastroenterol
Gamakaranage C, Butler TD, Ratcliffe E, Britton J, Keld R, Prasad N, Hamdy S, McLaughlin J, Ang Y.
PMID: 41825912 [PubMed - indexed for MEDLINE]


Editorial Comment to "Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan".
Int J Urol
Minato A.
PMID: 41825904 [PubMed - in process]


Long term use of proton pump inhibitors and risk of stomach cancer: population based case-control study in five Nordic countries.
BMJ

PMID: 41825878 [PubMed - in process]


Randomised trial of delivering co-located, personalised stop-smoking support within lung cancer screening: the YESS study.
Thorax
Murray RL, Baldwin D, Brain K, Britton J, Chalitsios CV, Crosbie PA, Lewis S, McCutchan G, Steve P, Quaife S, Thorley R, Wu Q, Ashurst A, Beeken RJ, Copeland H, Gabe R, Hancock N, Marshall CS, Neal RD, Porter LR, Rogerson S, Quinn-Scoggins HD, Simmonds I, Sloss A, Callister MEJ.
PMID: 41825863 [PubMed - as supplied by publisher]


Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy with either cisplatin or cetuximab in the NRG/RTOG 1016 randomized controlled trial.
Int J Radiat Oncol Biol Phys
Ringash J, Torres-Saavedra PA, Gillison ML, Caudell JJ, Adelstein DJ, Harari PM, Sturgis EM, Basch E, Koyfman SA, Krempl GA, Blakaj DM, Bates JE, Galloway TJ, Jones CU, Beadle BM, Harris J, Le QT, Yom SS, Movsas B.
PMID: 41825810 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 1918471    Page 1 of 95924  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1